Luyan Pharma Co Ltd (002788) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥118.98 Million ≈ $17.41 Million USD) by net assets (CN¥3.26 Billion ≈ $477.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002788 net asset quality index to measure how much of total assets are equity-financed.

Luyan Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Luyan Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002788 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Luyan Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luyan Pharma Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Myriad Genetics Inc NASDAQ:MYGN	-0.047x
Dat Xanh Real Estate Service Contructions Corp VN:DXG	0.024x
Gigalane Co Ltd KQ:049080	-0.089x
Anshan Hifichem Co Ltd SHE:300758	0.020x
Ningbo Sinyuan ZM Technology Co. Ltd. A SHE:301398	N/A
Ur Energy Inc NYSE MKT:URG	-0.166x
Ambassador Hotel Ltd TW:2704	0.009x
Nanjing Develop Advanced Manufacturing Co Ltd SHG:688377	0.048x

Annual Cash Flow Conversion Efficiency for Luyan Pharma Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Luyan Pharma Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Luyan Pharma Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.32 Billion ≈ $486.42 Million	CN¥688.40 Million ≈ $100.73 Million	0.207x	+14.47%
2024-12-31	CN¥3.19 Billion ≈ $467.08 Million	CN¥577.48 Million ≈ $84.50 Million	0.181x	-58.86%
2023-12-31	CN¥2.98 Billion ≈ $435.62 Million	CN¥1.31 Billion ≈ $191.57 Million	0.440x	+428.54%
2022-12-31	CN¥2.79 Billion ≈ $408.36 Million	CN¥232.19 Million ≈ $33.98 Million	0.083x	+157.26%
2021-12-31	CN¥2.56 Billion ≈ $374.63 Million	CN¥-372.02 Million ≈ $-54.44 Million	-0.145x	-552.79%
2020-12-31	CN¥2.41 Billion ≈ $352.11 Million	CN¥77.22 Million ≈ $11.30 Million	0.032x	+109.63%
2019-12-31	CN¥1.89 Billion ≈ $276.28 Million	CN¥-629.14 Million ≈ $-92.06 Million	-0.333x	-534.66%
2018-12-31	CN¥1.65 Billion ≈ $241.97 Million	CN¥126.77 Million ≈ $18.55 Million	0.077x	+126.85%
2017-12-31	CN¥1.57 Billion ≈ $229.21 Million	CN¥-447.16 Million ≈ $-65.43 Million	-0.285x	-207.31%
2016-12-31	CN¥1.38 Billion ≈ $201.67 Million	CN¥-128.03 Million ≈ $-18.73 Million	-0.093x	-31699.60%
2015-12-31	CN¥746.00 Million ≈ $109.16 Million	CN¥219.31K ≈ $32.09K	0.000x	-99.89%
2014-12-31	CN¥649.30 Million ≈ $95.01 Million	CN¥177.89 Million ≈ $26.03 Million	0.274x	+299.88%
2013-12-31	CN¥557.87 Million ≈ $81.63 Million	CN¥-76.47 Million ≈ $-11.19 Million	-0.137x	-86.46%
2012-12-31	CN¥448.15 Million ≈ $65.58 Million	CN¥-32.94 Million ≈ $-4.82 Million	-0.074x	-193.16%
2011-12-31	CN¥354.91 Million ≈ $51.93 Million	CN¥28.01 Million ≈ $4.10 Million	0.079x	--

About Luyan Pharma Co Ltd

SHE:002788 China Pharmaceutical Retailers

Market Cap

$534.41 Million

CN¥3.65 Billion CNY

Market Cap Rank

#11654 Global

#3192 in China

Share Price

CN¥9.40

Change (1 day)

+0.11%

52-Week Range

CN¥7.99 - CN¥27.49

All Time High

CN¥22328.40